Treatment of oligohydramnios with maternal 1-deamino-[8-D-arginine] vasopressin-induced plasma hypoosmolality

被引:20
作者
Ross, MG [1 ]
Cedars, L [1 ]
Nijland, MJM [1 ]
Ogundipe, A [1 ]
机构
[1] KING DREW MED CTR,LOS ANGELES,CA
关键词
D O I
10.1016/S0002-9378(96)70615-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Maternal 1-deamino-[8-D-arginine] vasopressin (a selective antidiuretic agonist) and oral water loading decrease maternal and fetal plasma osmolality and markedly increase fetal urine flow in sheep. We hypothesized that a titrated reduction in maternal plasma osmolality would increase human amniotic fluid volume. STUDY DESIGN: Pregnant women (n = 5) with oligohydramnios at term were administered oral water loading (20 ml/kg) and intravenous 1-deamino-[8-D-arginine] vasopressin (2 mu g) to induce antidiuresis. Maternal plasma and urine osmolality and urine production were measured hourly, and water replacement was titrated for 8 hours to reduce plasma osmolality by 15 to 20 mOsm/kg. The amniotic fluid index determined by ultrasonography was measured at baseline, 8 hours, and 24 hours. A control group of pregnant women (n = 5) with oligohydramnios at term was observed for 8 hours with maintenance intravenous hydration. RESULTS: In 1-deamino-[8-D-arginine] vasopressin-treated women, maternal urine flow increased with oral water loading, decreased with 1-deamino-[8-D-arginine] vasopressin administration, and remained reduced for 8 hours. Maternal plasma osmolality significantly decreased (285 +/- 4 to 265 +/- 4 mOsm/kg) and the amniotic fluid index significantly increased (4.1 +/- 0.6 to 8.2 +/- 1.5 cm) at 8 hours. Although maternal urine osmolality returned to basal values at 24 hours, plasma osmolality was reduced and the amniotic fluid index remained significantly increased (8.2 +/- 1.3 cm). There was no change in the amniotic fluid index (4.3 +/- 0.4 to 4.7 +/- 0.7 cm) in control patients observed with maintenance intravenous hydration. CONCLUSIONS: Maternal 1-deamino-[8-D-arginine] vasopressin and oral water administration can reduce and stabilize plasma osmolality and increase amniotic fluid volume. 1-Deamino-[8-D-arginine] vasopressin therapy has potential for the prevention and treatment of oligohydramnios.
引用
收藏
页码:1608 / 1613
页数:6
相关论文
共 27 条
[1]   TRANSPLACENTAL, AMNIOTIC, URINARY, AND FETAL FLUID-DYNAMICS DURING VERY-LARGE-VOLUME FETAL INTRAVENOUS INFUSIONS [J].
BRACE, RA ;
MOORE, TR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (03) :907-916
[2]   ALTERED OSMOTIC THRESHOLDS FOR VASOPRESSIN SECRETION AND THIRST IN HUMAN-PREGNANCY [J].
DAVISON, JM ;
GILMORE, EA ;
DURR, J ;
ROBERTSON, GL ;
LINDHEIMER, MD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 246 (01) :F105-F109
[3]  
DECAUX G, 1994, J LAB CLIN MED, V123, P892
[4]   MODEL STUDY OF PLACENTAL WATER TRANSFER AND CAUSES OF FETAL WATER DISEASE IN SHEEP [J].
FABER, JJ ;
ANDERSON, DF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (05) :R1257-R1270
[5]  
GILBERT WM, 1989, OBSTET GYNECOL, V74, P748
[6]   CLINICAL SIGNS OF NORMAL PLASMA-VOLUME EXPANSION DURING PREGNANCY [J].
GOODLIN, RC ;
DOBRY, CA ;
ANDERSON, JC ;
WOODS, RE ;
QUAIFE, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983, 145 (08) :1001-1009
[7]   COMPOSITION AND VOLUME OF FLUID SWALLOWED BY FETAL SHEEP [J].
HARDING, R ;
BOCKING, AD ;
SIGGER, JN ;
WICKHAM, PJD .
QUARTERLY JOURNAL OF EXPERIMENTAL PHYSIOLOGY AND COGNATE MEDICAL SCIENCES, 1984, 69 (03) :487-495
[8]  
HEDRIANA HL, 1994, AM J OBSTET GYNECOL, V170, P1250
[9]   RENAL RESPONSES OF FETAL LAMB TO FETAL OR MATERNAL VOLUME EXPANSION [J].
HURLEY, JK ;
KIRKPATRICK, SE ;
PITLICK, PT ;
FRIEDMAN, WF ;
MENDOZA, SA .
CIRCULATION RESEARCH, 1977, 40 (06) :557-560
[10]  
KARSDORP VHM, 1992, OBSTET GYNECOL, V80, P679